Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats

Gut

Volumn 62, Issue 1, 2013, Pages 138-145

  Ribera, Jordi ^b   Pauta, Montse ^b   Melgar Lesmes, Pedro ^b   Tugues, Sònia ^b,c   Fernández Varo, Guillermo ^b   Held, Kara F ^a   Soria, Guadalupe ^d   Tudela, Raúl ^a,d   Planas, Anna M ^d,e   Fernández Hernando, Carlos ^d   Arroyo, Vicente ^d   Jiménez, Wladimiro ^b,d   Morales Ruiz, Manuel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Rudbecklaboratoriet ^*  (Sweden)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDODRINE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; EDEMA; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; EXUDATE; FLUORESCENCE IMAGING; LIVER CIRRHOSIS; LYMPHANGIOGRAPHY; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; ASCITES; BIOLOGICAL MARKERS; CARBON TETRACHLORIDE; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; LIVER CIRRHOSIS; LYMPHATIC SYSTEM; LYMPHOGRAPHY; MALE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84871129149     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300703     Document Type: Article

References (26)

1. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-66. (Pubitemid 36775818)
2. Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-54.
3. Van Steenkiste C, Geerts A, Vanheule E, et al. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension. Gastroenterology 2009;137:2112-24.
4. Henriksen JH, Moller S. Alterations of hepatic and splanchnic microvascular exchange in cirrhosis: local factors in the formation of ascites. In: Gines P, Arroyo V, Rodes J, et al, eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis and Treatment . Malden, MA: Blackwell Publishing, 2005:174-85.
5. Bhunchet E, Fujieda K. Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow. Hepatology 1993;18 :1450-8. (Pubitemid 23348436)
6. Mori T, Okanoue T, Sawa Y, et al. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 1993;17:891-7. (Pubitemid 23150099)
7. Melgar-Lesmes P, Tugues S, Ros J, et al. Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats. Gut 2009;58:285-92.
8. Cardenas A, Bataller R, Arroyo V. Mechanisms of ascites formation. Clin Liver Dis 2000;4:447-65. (Pubitemid 30460832)
9. Schmid-Schonbein GW. Microlymphatics and lymph flow. Physiol Rev 1990;70:987-1028. (Pubitemid 20364821)
10. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 1993;73:1-78. (Pubitemid 23065433)
11. Hagendoorn J, Padera TP, Kashiwagi S, et al. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res 2004;95:204-9. (Pubitemid 38988687)
12. Witte MH, Dumont AE, Cole WR, et al. Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med 1969;70:303-10.
13. Tugues S, Morales-Ruiz M, Fernandez-Varo G, et al. Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats. Gastroenterology 2005;129:1686-95. (Pubitemid 41597407)
14. Ros J, Jimenez W, Lamas S, et al. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 1995;21:554-60.
15. Fernandez-Varo G, Ros J, Morales-Ruiz M, et al. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. Am J Pathol 2003;162:1985-93. (Pubitemid 36613055)
16. Morales-Ruiz M, Cejudo-Martin P, Fernandez-Varo G, et al. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 2003;125:522-31. (Pubitemid 36929434)
17. Thibeault S, Rautureau Y, Oubaha M, et al. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell 2010;39:468-76.
18. Dumont AE, Mulholland JH. Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med 1960;263 :471-4.
19. Witte CL, Witte MH, Dumont AE. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 1980;78:1059-68. (Pubitemid 10120927)
20. Henriksen JH. Estimation of lymphatic conductance. A model based on proteinkinetic studies and haemodynamic measurements in patients with cirrhosis of the liver and in pigs. Scand J Clin Lab Invest 1985;45:123-30. (Pubitemid 15106622)
21. Martin PY, Ohara M, Gines P, et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998;101:235-42. (Pubitemid 28058923)
22. Graebe M, Brond L, Christensen S, et al. Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats. Am J Physiol Renal Physiol 2004;286:288-97.
23. Cardenas A, Curry M, Afdhal NH. The not so good effects of nitric oxide inhibition with methylene blue in cirrhosis and ascites. Dig Dis Sci 2007;52:939-40. (Pubitemid 46481235)
24. Thiesson HC, Skott O, Jespersen B, et al. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites. Am J Gastroenterol 2003;98:180-6. (Pubitemid 36135188)
25. Morales-Ruiz M, Jimenez W. Pathophysiological role of nitric oxide in cirrhosis. In: Arroyo V, Ginés P, Rodés J, et al, eds. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis Diagnosis and Treatment. Malden, Massachussets: Blackwell Science Inc, 2005:105-14.
26. Langer DA, Shah VH. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis. J Hepatol 2006;44:209-16. (Pubitemid 41772536)